In reply to Simcock et al.

by Stefano Maria Magrini, Rosario Mazzola, Diana Greco, Filippo Alongi, Michela Buglione
Published 2020-07-01

P188 EFFECTS OF RADIOTHERAPY ON LARGE VESSELS IN HODGKIN LYMPHOMA SURVIVORS

by Anna Paini, Massimo Salvetti, Michela Buglione, Fabio Bertacchini, Giulia Maruelli, Francesca Trevisan, Liliana Baushi, Stefano Maria Magrini, Maria Lorenza Muiesan
Published 2017-12-01

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer

by Francesco Cuccia, Stefanie Corradini, Rosario Mazzola, Luigi Spiazzi, Michele Rigo, Marco Lorenzo Bonù, Ruggero Ruggieri, Michela Buglione di Monale e Bastia, Stefano Maria Magrini, Filippo Alongi
Published 2021-04-01

Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature

by Andrea Emanuele Guerini, Luca Triggiani, Marta Maddalo, Marco Lorenzo Bonù, Francesco Frassine, Anna Baiguini, Alessandro Alghisi, Davide Tomasini, Paolo Borghetti, Nadia Pasinetti, Roberto Bresciani, Stefano Maria Magrini, Michela Buglione
Published 2019-08-01

CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis

by Lucio De Maria, Lodovico Terzi di Bergamo, Alfredo Conti, Kazuhiko Hayashi, Valentina Pinzi, Taro Murai, Rachelle Lanciano, Sigita Burneikiene, Michela Buglione di Monale, Stefano Maria Magrini, Marco Maria Fontanella
Published 2021-03-01

Light and shadows of a new technique: is photon total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one?

by Michela Buglione, Luigi Spiazzi, Mauro Urpis, Liliana Baushi, Rossella Avitabile, Nadia Pasinetti, Paolo Borghetti, Luca Triggiani, Sara Pedretti, Federica Saiani, Alfredo Fiume, Diana Greco, Stefano Ciccarelli, Alessia Polonini, Renzo Moretti, Stefano Maria Magrini
Published 2018-08-01

Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice

by Michela Buglione, Luigi Spiazzi, Andrea Emanuele Guerini, Fernando Barbera, Nadia Pasinetti, Ludovica Pegurri, Luca Triggiani, Davide Tomasini, Diana Greco, Gianluca Costantino, Alessandra Bragaglio, Nadia Bonometti, Mara Liccioli, Lorella Mascaro, Radiation Oncology Department Staff, Filippo Alongi, Stefano Maria Magrini
Published 2020-08-01

Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study

by Angelo Porreca, Marianna Noale, Walter Artibani, Pier Francesco Bassi, Filippo Bertoni, Sergio Bracarda, Giario Natale Conti, Renzo Corvò, Mauro Gacci, Pierpaolo Graziotti, Stefano Maria Magrini, Vincenzo Mirone, Rodolfo Montironi, Giovanni Muto, Stefano Pecoraro, Umberto Ricardi, Elvio Russi, Andrea Tubaro, Vittorina Zagonel, Gaetano Crepaldi, Stefania Maggi, the Pros-IT CNR study group
Published 2018-06-01

How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the...

by Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, Alessia Guarneri, Sara Bartoncini, Paolo Antognoni, Stefania Gottardo, Diana Greco, Simona Borghesi, Sara Nanni, Alessio Bruni, Gianluca Ingrosso, Rolando Maria D’Angelillo, Beatrice Detti, Giulio Francolini, Alessandro Magli, Andrea Emanuele Guerini, Stefano Arcangeli, Luigi Spiazzi, Umberto Ricardi, Frank Lohr, Stefano Maria Magrini
Published 2021-05-01

Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR).

by Michela Buglione, Marianna Noale, Alessio Bruni, Alessandro Antonelli, Filippo Bertoni, Renzo Corvo', Umberto Ricardi, Paolo Borghetti, Marta Maddalo, Claudio Simeone, Ercole Mazzeo, Angelo Porreca, Sergio Serni, Pierfrancesco Bassi, Mauro Gacci, Vincenzo Mirone, Rodolfo Montironi, Andrea Tubaro, Alfredo Berruti, Giario Natale Conti, Stefania Maggi, Stefano Maria Magrini, Luca Triggiani, Pros-IT CNR study group
Published 2019-01-01

A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer

by Alessio Bruni, Vieri Scotti, Paolo Borghetti, Stefano Vagge, Salvatore Cozzi, Elisa D’Angelo, Niccolò Giaj Levra, Alessandra Fozza, Maria Taraborrelli, Gaia Piperno, Valentina Vanoni, Matteo Sepulcri, Marco Trovò, Valerio Nardone, Elisabetta Lattanzi, Said Bou Selman, Federica Bertolini, Davide Franceschini, Francesco Agustoni, Barbara Alicja Jereczek-Fossa, Barbara Alicja Jereczek-Fossa, Stefano Maria Magrini, Lorenzo Livi, Frank Lohr, Andrea Riccardo Filippi
Published 2021-09-01